pharma · Rheumatoid arthritis · Completely Resected Stage IIB, IIC, and III Melanoma
Celltrion Healthcare Australia
Celltrion Healthcare Australia Pty Ltd
Celltrion Healthcare Australia clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Sydney, AU
- Employees
- 9
- Programs
- 10
- Drugs
- 44
- Patents
- 0
Celltrion Healthcare Australia projects
4 ClinicalTrials.gov programs sponsored by Celltrion Healthcare Australia.
Celltrion Healthcare Australia has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CT-G11
Celltrion Healthcare Australia Pty Ltd
Healthy
1 trial -
CT-P41
Celltrion Healthcare Australia Pty Ltd
Healthy Male Subjects
1 trial -
CT-P51 1.1
Celltrion Healthcare Australia Pty Ltd
Completely Resected Stage IIB, IIC, and III Melanoma
1 trial -
CT-P6 SC
Celltrion Healthcare Australia Pty Ltd
Healthy
1 trial
Frequently asked questions
How many clinical projects does Celltrion Healthcare Australia have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.